Dow Jones

39,512.84

0.32%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

BLRX

BioLineRx (BLRX)

BioLineRx Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BLRX

1 2 3 4 5 6 7 8 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
06/05/2024	06:14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BLRX	BioLineRx Ltd
17/04/2024	06:00	PR Newswire (US)	BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting	NASDAQ:BLRX	BioLineRx Ltd
07/01/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BLRX	BioLineRx Ltd
29/12/2023	15:20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BLRX	BioLineRx Ltd
29/12/2023	15:15	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:BLRX	BioLineRx Ltd
20/11/2023	05:25	IH Market News	Monday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and more	NASDAQ:BLRX	BioLineRx Ltd
01/11/2023	06:43	PR Newswire (Canada)	BioLineRx a conclu un accord de licence exclusive pour le motixafortide en Asie, sous les conseils de MSQ Ventures	NASDAQ:BLRX	BioLineRx Ltd
31/10/2023	08:00	PR Newswire (US)	BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. Ventures	NASDAQ:BLRX	BioLineRx Ltd
26/10/2023	13:18	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:BLRX	BioLineRx Ltd
18/10/2023	16:07	AllPennyStocks.com	New Collaboration Could Revolutionize Treatment of Chronic Spinal Cord Injuries	NASDAQ:BLRX	BioLineRx Ltd
11/09/2023	06:00	PR Newswire (US)	BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple Myeloma	NASDAQ:BLRX	BioLineRx Ltd
30/08/2023	06:16	IH Market News	Wednesday’s Wall Street Highlights: Ambarella, Alphabet, Toyota, HP Inc, Vinfast, and more	NASDAQ:BLRX	BioLineRx Ltd
23/06/2023	15:17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:BLRX	BioLineRx Ltd
22/03/2023	06:48	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:BLRX	BioLineRx Ltd
20/01/2023	15:32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:BLRX	BioLineRx Ltd
15/11/2022	11:05	TipRanks	Bioline RX Ltd Sponsored ADR (BLRX) Receives a Buy from H.C. Wainwright	NASDAQ:BLRX	BioLineRx Ltd
04/11/2022	15:30	PR Newswire (US)	BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification	NASDAQ:BLRX	BioLineRx Ltd
28/09/2022	11:15	TipRanks	Bioline RX Ltd Sponsored ADR (BLRX) Gets a Buy from H.C. Wainwright	NASDAQ:BLRX	BioLineRx Ltd
20/09/2022	15:31	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:BLRX	BioLineRx Ltd
19/09/2022	09:53	TipRanks	BioLineRx (NASDAQ:BLRX) Nosedives on $15M Direct Offering	NASDAQ:BLRX	BioLineRx Ltd
09/09/2022	15:16	Edgar (US Regulatory)	Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)	NASDAQ:BLRX	BioLineRx Ltd
30/06/2022	08:42	PR Newswire (Canada)	BioLineRx conclut une entente de codéveloppement avec GenFleet pour développer davantage le Motixafortide pour le traitement de l'adénocarcinome canalaire pancréatique, selon les conseils de MSQ Ventures	NASDAQ:BLRX	BioLineRx Ltd
29/06/2022	07:00	PR Newswire (Canada)	BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures	NASDAQ:BLRX	BioLineRx Ltd
16/03/2022	10:15	TipRanks	H.C. Wainwright Thinks Biolinerx’s Stock is Going to Recover	NASDAQ:BLRX	BioLineRx Ltd
11/02/2022	05:50	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BLRX	BioLineRx Ltd
18/01/2022	10:40	TipRanks	Biolinerx (BLRX) Receives a Buy from H.C. Wainwright	NASDAQ:BLRX	BioLineRx Ltd
21/09/2021	11:13	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:BLRX	BioLineRx Ltd
25/02/2021	05:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BLRX	BioLineRx Ltd
23/02/2021	08:13	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:BLRX	BioLineRx Ltd
28/01/2021	10:31	TipRanks	These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts	NASDAQ:BLRX	BioLineRx Ltd